Financial BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results byTim AllenJune 17, 2024
Financial Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance byJosh SandbergMay 8, 2024
Financial ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance byJosh SandbergMay 7, 2024
Financial Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program byJosh SandbergMay 7, 2024
Financial Vicarious Surgical Reports First Quarter 2024 Financial Results byJosh SandbergApril 29, 2024
Financial Spine Centinel Spine® Hits Another Revenue Record in First Quarter 2024 as ,Total Disc Replacement Worldwide Growth Momentum Continues byTim AllenApril 23, 2024
